TransformingHealthcare one
company at a time

About Us

Edge Medical Ventures is a medtech-focused venture studio and fund managed by industry veterans with extensive operational experience.

Our mission is to create or identify ventures that offer significant market opportunities by addressing critical clinical unmet needs through the development and investment in breakthrough medical device technologies.

Our venture studio, EdgeLabs, is designed to start from a unmet need posed by our strategic collaborators. Our later-stage fund, EdgeMED, typically invests in seed, Series A, and early Series B rounds (up to $3M)—primarily at the clinical stage.

A key goal of Edge is to act as a bridge between Israeli innovation and the U.S. market, by actively supporting our portfolio companies in making this transition. This includes guidance in clinical operations, preparation for commercial launch, networking with leading U.S. healthcare systems, and establishing U.S.-based offices and personnel. We achieve this through our strong collaborations with strategic players, healthcare systems, and investors across the United States.

Venture Creation Studio based on validated unmet market needs

Venture Capital Fund focused on investing in medical device companies

Our Origins: From MEDX to Edge

Built on Experience. Driven by Vision.

Edge Medical Ventures was founded by the leadership team of MEDX Xelerator—Israel’s leading medical device incubator. Since 2018, MEDX has launched and invested in 18 medical device companies, shaping a new generation of healthcare innovation.

To continue supporting these companies beyond their incubation phase—and to back the next wave of transformative technologies—we founded Edge. 

Edge Medical Ventures is the natural evolution of our journey: a fund built on deep operational experience, clinical insight, and a track record of value creation in early-stage Medtech.

Through Edge, we extend the lifecycle of support that began at MEDX—investing in bold ideas and scaling breakthrough solutions to global impact.

Learn more about MEDX Xelerator 

Areas of Interest

Venture Roadmap

You have a venture
Send an email
Send us an email to info@edgemed.vc with a presentation and a one-page explanation about your venture.
~ After 2 weeks
Meet with us
We will invite you to a meeting with the Edge Medical venture team in our offices, where we could hear more and discuss your venture.
~ After 2 weeks
~ After 4 weeks
Begin due diligence
We will sign a “confidential disclosure agreement” (CDA) and begin a constructive due diligence process.
~ After 4 weeks
~ After 2-3 months
Investment committee
Once due diligence is complete, we will present the project to Edge Medical venture’s investment committee.
~ After 2-3 months
~ After 2 weeks
Join EMV portfolio
Once the project is approved by our investment committee, you will Join Edge Medical venture Family.
~ After 2 weeks
You have a venture
Send an email
Send us an email to info@edgemed.vc with a presentation or a one-page about your venture.
Meet with us
We will invite you to a meeting with the Edge Medical venture team in our offices, where we could hear more and discuss your venture.
Begin due diligence
We will sign a “confidential disclosure agreement” (CDA) and begin a constructive due diligence process.
Investment committee
Once due diligence is complete, we will present the project to Edge Medical venture’s investment committee.
Join EMV portfolio
Once the project is approved by our investment committee, you will Join Edge Medical venture Family.
~ 2 weeks
~ 4 weeks
~ 2-3 months
~ 2 weeks

Our Team

gal1a

Gal Atarot

Co-founder and managing partner

CTO of MEDX Xelerator
Prev: MST (acq. by Transenterix)
MSc, Biomedical EngTechnion
BSc, Mechanical Eng, Technion

shai

Shai Policker

Co-founder and managing partner

CEO of MEDX Xelerator
Prev: EndoStim, Impulse Dynamics
BSc, Electrical Eng, Technion
MBA, Columbia U

noam

Noam Taichler

Co-founder and managing partner

CFO of MEDX Xelerator
Prev: CFO at Hutchison Kinrotand
MBA, Tel Aviv U
BA, Mgmt, Accounting Economics, Tel Aviv U

anya

Anya Eldan

Partner

Prev: VP, Israel Innovation Authority & CEO,
WideMed (TASE:WDMD)
Managing Partner,
Platinum Venture Capital
MBA, BSc, Tel Aviv U, Magna Cum Laude

Stephen-Solomon

Dr. Stephen Solomon

Partner

Chief of Interventional Radiology,
Memorial Sloan Kettering
Prev: Venture Partner at Cutlass Capital
MD, Yale
BA, Harvard

Eillen

Eileen Ke

Chief Commercial Officer

COO, Night Watch
Investment Management
Prev: Strategy & Marketing at Stryker, EndoStim
MBA, WashU
MS Finance, WashU

dylan

Dr. Dylan Attard

Venture Partner

CEO and Co-founder,
MedTech World
MD Medicine and Surgery, University of Malta, Royal College of Surgeons in Ireland

Portfolio

e_LOGO

Exero Medical (6/24)

Early detection of postoperative
Anastomotic leak

More

Portfolio

exero2

Exero Medical (6/24)

Early detection of postoperative
anastomotic leaks

More
_0002_Synchrony-Medical

Synchrony Medical (8/24)

Remote chest physical therapy system for effective airway clearance

More
_0000_PatenSee

PatenSee (8/24)

Transforming surveillance of dialysis patients

More
apend2

Append Medical (8/24)

Transseptal LAA closure system without the need for an implant

More
lifecord

Lifecord (4/25)

Leaflet preserving transfemoral mitral chordal repair system

More

If you have a big , back it heavily because you don’t get a big often. Opportunity comes, but it doesn’t come often, so seize it when it does come

Charlie Munger

In the News

We'd Love To Hear From You

visit us Here